| Autor: |
Pasini A; Nephrology and Dialysis Unit, Department of Pediatrics, Azienda Ospedaliero Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy. andrea.pasini@aosp.bo.it., Benetti E; Pediatric Nephrology, Dialysis and Transplant Unit, Department of Pediatrics, University Hospital of Padua, Padua, Italy., Conti G; Pediatric Nephrology and Rheumatology Unit with Dialysis, AOU G. Martino, Messina, Italy., Ghio L; Pediatric Nephrology and Dialysis Unit, Fondazione Ca' Granda, IRCCS Ospedale Maggiore, Policlinico Milano, Milan, Italy., Lepore M; Pediatric Nephrology and Dialysis Unit, Fondazione Ca' Granda, IRCCS Ospedale Maggiore, Policlinico Milano, Milan, Italy., Massella L; Nephrology and Dialysis Unit, Pediatric Subspecialties Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Molino D; Santobono Children's Hospital, Naples, Italy., Peruzzi L; City of the Health and the Science of Turin Health Agency, Regina Margherita Children's Hospital, Turin, Italy., Emma F; Nephrology and Dialysis Unit, Pediatric Subspecialties Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Fede C; Pediatric Nephrology and Rheumatology Unit with Dialysis, AOU G. Martino, Messina, Italy., Trivelli A; Division of Nephrology, Dialysis, Transplantation, and Laboratory on Pathophysiology of Uremia, Istituto G. Gaslini, Genoa, Italy., Maringhini S; Pediatric Nephrology Unit, Children's Hospital 'G. Di Cristina', A.R.N.A.S. 'Civico', Palermo, Italy., Materassi M; Nephrology and Dialysis Unit, Meyer Children's Hospital, Florence, Italy., Messina G; Nephrology Unit, Giovanni XXIII Children's Hospital, Bari, Italy., Montini G; Pediatric Nephrology and Dialysis Unit, Fondazione Ca' Granda, IRCCS Ospedale Maggiore, Policlinico Milano, Milan, Italy., Murer L; Pediatric Nephrology, Dialysis and Transplant Unit, Department of Pediatrics, University Hospital of Padua, Padua, Italy., Pecoraro C; Santobono Children's Hospital, Naples, Italy., Pennesi M; Institute of Maternal and Child Health IRCCS 'Burlo Garofolo', Department of Pediatrics, Trieste, Italy. |
| Abstrakt: |
This consensus document is aimed at providing an updated, multidisciplinary overview on the diagnosis and treatment of pediatric nephrotic syndrome (NS) at first presentation. It is the first consensus document of its kind to be produced by all the pediatric nephrology centres in Italy, in line with what is already present in other countries such as France, Germany and the USA. It is based on the current knowledge surrounding the symptomatic and steroid treatment of NS, with a view to providing the basis for a separate consensus document on the treatment of relapses. NS is one of the most common pediatric glomerular diseases, with an incidence of around 2-7 cases per 100000 children per year. Corticosteroids are the mainstay of treatment, but the optimal therapeutic regimen for managing childhood idiopathic NS is still under debate. In Italy, shared treatment guidelines were lacking and, consequently, the choice of steroid regimen was based on the clinical expertise of each individual unit. On the basis of the 2015 Cochrane systematic review, KDIGO Guidelines and more recent data from the literature, this working group, with the contribution of all the pediatric nephrology centres in Italy and on the behalf of the Italian Society of Pediatric Nephrology, has produced a shared steroid protocol that will be useful for National Health System hospitals and pediatricians. Investigations at initial presentation and the principal causes of NS to be screened are suggested. In the early phase of the disease, symptomatic treatment is also important as many severe complications can occur which are either directly related to the pathophysiology of the underlying NS or to the steroid treatment itself. To date, very few studies have been published on the prophylaxis and treatment of these early complications, while recommendations are either lacking or conflicting. This consensus provides indications for the prevention, early recognition and treatment of these complications (management of edema and hypovolemia, therapy and prophylaxis of infections and thromboembolic events). Finally, recommendations about the clinical definition of steroid resistance and its initial diagnostic management, as well as indications for renal biopsy are provided. |
